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During a 2-month period, five patients suffering from invasive infections caused by Aspergillus flavus or
Aspergillus fumigatus were identified in the Hematology Department of the University Hospital Dijkzigt (Rot-
terdam, The Netherlands). To study the epidemiological aspects of invasive aspergillosis, strains from these
patients and from the hospital environment, isolated during extensive microbiological screening, were sub-
jected to genotyping. A novel DNA extraction technique, involving freezing, grinding, and direct lysis in guani-
dium isothiocyanate-containing buffers of mycelial material, was applied. DNA isolation was followed by typing
by random amplification of polymorphic DNA (RAPD) analysis. This showed that strains isolated from all
patients infected with the same fungal species were genotypically distinct, thus providing evidence against the
possibility of an ongoing, single-source nosocomial outbreak. Strains could also be differentiated from strains
of geographically diverse origins. However, an A. flavus strain from one of the patients was also frequently
encountered in the hospital environment. As all environmental strains were collected after this patient had
been diagnosed with invasive disease, the epidemiological value of this observation could not be ascertained.
Intensive investigations showed no single source of A. flavus or other aspergilli. RAPD genotyping proved that
the outbreak of invasive aspergillosis in the hematology ward consisted of a series of unrelated events and was
not due to a common source within the hospital. RAPD fingerprinting of aspergilli may greatly facilitate future
investigations of the epidemiology of invasive disease caused by these pathogens.
Aspergillus spp. are widely distributed fungi which, after their
conidia are inhaled, can cause invasive, usually pulmonary in-
fection in immunocompromised patients (19). In oncology pa-
tients with prolonged neutropenia, Aspergillus sp. infections
represent an increasing problem (1). Aspergillus fumigatus is by
far the predominant species in cases of invasive disease; A.
flavus is isolated less frequently but more often causes ex-
trapulmonary invasive infections (2, 13). As the prophylactic
and therapeutic efficacies of the present antifungal agents are
insufficient in many cases, it is important to protect susceptible
patients from inhaling Aspergillus conidia. Adequate protective
isolation by using high-efficiency particulate air (HEPA) filtra-
tion currently provides the best barrier against invasive fungal
disease. Nevertheless, small outbreaks of nosocomial aspergil-
losis have been reported, sometimes in association with envi-
ronmental sources of conidia (23, 26). Elucidation of the com-
plex epidemiology in such cases requires detailed molecular
typing studies. However, not all of the molecular procedures
are applicable to fungal typing (12, 15, 22, 23).
During an apparent outbreak of nosocomial aspergillosis in
the University Hospital Rotterdam, clinical and environmental
isolates of A. flavus and A. fumigatus were collected. The pos-
sible role of Aspergillus genotyping in managing such outbreaks
was investigated, and measures taken at the time of the out-
break were retrospectively reevaluated. The present report
describes a novel DNA extraction method and the application
of randomly amplified polymorphic DNA (RAPD) analysis as
a genotyping method. The value of different primers for dis-
tinguishing among strains of A. flavus as well as A. fumigatus
was determined.
MATERIALS AND METHODS
The epidemiological and patient-related procedures and the laboratory tech-
niques for typing of isolates of Aspergillus spp. are described below under two
separate headings.
Patients and environmental screening. (i) Invasive aspergillosis. A patient
was diagnosed to have invasive aspergillosis when Aspergillus spp. were cultured,
in the absence of other pathogens which could explain clinical symptoms, from
bronchoalveolar lavage (BAL) fluid or from deep tissue specimens. Invasive
disease was confirmed by histopathology. X-ray analysis and drug response were
also used to corroborate the diagnosis of invasive disease. Five patients within
the hematology ward were diagnosed with invasive aspergillosis during the pe-
riod from May to July 1994.
(ii) Prophylaxis. To prevent development of invasive aspergillosis in other
patients, prophylactic measures were taken. Windows were kept closed through-
out the entire hospital. Patients in the hematology ward received one of two
antifungal prophylactic regimens on a daily basis: 10 mg of aerosolized ampho-
tericin B in combination with either itraconazole (200 mg orally) or amphotericin
B (0.5 mg/kg of body weight intravenously). This last regimen was given to
patients who were neutropenic (neutrophilic granulocyte count of less than
0.5 z 109) during the outbreak period, because of potential exposure to high levels
of fungal conidia.
(iii) Air sampling. To study the numbers of conidia in the hospital air, serial
air samples of 1 m3 each were taken twice a week with a surface air system
sampler containing Sabouraud agar plates, which were incubated at 22 and 378C
to examine growth of both nonpathogenic and pathogenic fungi. Similar air
samples were taken just outside the hospital and at a nearby demolition site.
(iv) Air-conditioning and filtration systems. To allow investigation of the
air-conditioning systems and HEPA filters, patients were temporarily moved to
a new building. During the first 2 weeks of closure of the old department, several
air samples were taken. After this period, the ceilings were removed and ana-
lyzed for fungal growth. The air-conditioning and filtration systems were opened
and also studied. Swabs and air samples were taken from within the systems and
other suspicious sites. HEPA filters were removed and studied for fungal growth,
and new filters were installed.
Fungal strains and DNA typing. (i) Fungal isolates. Isolates of A. flavus and
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A. fumigatus were collected from patients with invasive aspergillosis nursed in the
hematology ward of the University Hospital Dijkzigt (Rotterdam, The Nether-
lands). Additional isolates were collected from patients treated on other wards
and from various environmental sources (within and outside the hospital). Ad-
ditional clinical isolates of A. flavus were obtained from the Department of
Medical Microbiology, University Hospital Nijmegen (Nijmegen, The Nether-
lands), the Regional Laboratory for Public Health Haarlem (Haarlem, The
Netherlands), and the Diagnostic Microbiology Laboratory of the University of
Minnesota (Minneapolis). Species were identified on the basis of culture char-
acteristics and morphology of conidiophores and conidia. Strains were propa-
gated on Sabouraud media and stored at 2708C in brain heart infusion (BHI)
broth containing 10% glycerol.
(ii) Fungal DNA isolation. Strains were inoculated in 25 ml of Sabouraud
maltose medium containing 4 mg of gentamicin per ml, and the culture was
incubated at 378C for 72 h until abundant mycelial growth was observed. The
entire thallus was collected in a porcelain bowl. Liquid nitrogen was added, after
which grinding of the frozen material took place. Between 10 and 25 ml of lysis
buffer (0.1 M Tris-HCl [pH 6.4], 40 mM EDTA [pH 8.0], 1% Triton X-100, 4 M
guanidium isothiocyanate) was added, work being carried out in a safety cabinet.
This suspension could be stored for various periods at 2208C. DNA degradation
was prohibited by the immediate lysis of destroyed cells and guanidium isothio-
cyanate-induced protein denaturation. One milliliter of the extract was centri-
fuged for 5 min (15,000 rpm) (Eppendorf centrifuge; Merck). To the superna-
tant, 100 ml of a Celite suspension (200 mg/ml) (Aoroa organics, Grel, Belgium)
was added, and this suspension was shaken vigorously by hand. The pellet was
washed three times in a second lysis buffer (0.1 M Tris-HCl [pH 6.4], 4 M
guanidium isothiocyanate), 70% ethanol, and acetone, respectively (4). After
being dried, the pellet was resuspended in 150 ml of 10 mM Tris-HCl (pH 8.0)
and incubated at 568C for 10 min. Approximately 125 ml of the supernatant was
collected. The DNA concentration was estimated by electrophoresis of DNA-
containing aliquots through 1% agarose gels, run in 0.53 Tris-borate-EDTA in
the presence of ethidium bromide, and comparison with the staining intensities
of known amounts of bacteriophage lambda DNA.
(iii) PCR-mediated DNA fingerprinting. DNA typing by RAPD was per-
formed as described previously (14, 24, 25). Approximately 50 ng of fungal DNA
was subjected to 40 cycles of repeated denaturation (1 min, 948C), primer
annealing (1 min, 258C), and enzymatic chain extension (2 min, 748C) in 100 ml
of a buffer system consisting of 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 2.5 mM
MgCl2, 0.01% gelatin, 0.1% Triton X-100, 0.2 mM deoxynucleoside triphos-
phates, 50 pmol of primer, and 0.5 U of Thermus thermophilus DNA polymerase
(Sphaero Q, Leiden, The Netherlands). Initially, the enterobacterial repetitive
intergenic consensus primers ERIC-1 and ERIC-2 were employed in separate
assays (see Table 1 and reference 26). Sixteen additional primers were evaluated
with respect to their resolving power towards Aspergillus sp. DNA. The additional
primers selected on the basis of these experiments are listed in Table 1. The
resulting banding patterns were indexed by capital lettering, and even a single
band difference led to a different letter code. Differences in ethidium bromide
staining intensities were ignored. Upon combination of the results of multiple
assays, a single, 7-letter genocode was deduced. Banding patterns were inter-
preted visually by three independent persons. Reproducibility and reliability
were assessed as suggested previously (23).
(iv) PCR ribotyping. PCR ribotyping was performed as described for a number
of bacterial pathogens (5, 9). With primers sp1 and sp2 (see Table 5), the 16S-23S
intergenic spacer region was amplified by using a PCR program consisting of 40
cycles of alternating denaturation (1 min, 948C), primer annealing (1 min, 558C),
and primer extension (1 min, 748C). The reaction mixture components were
identical to those described above.
All PCRs were performed in a Biomed type 60 thermocycler (Biomed, Theres,
Germany), and after amplification, the DNA fragments were length separated by
electrophoresis through 0.8 to 2% agarose gels in 40 mM Tris-acetate (pH 7.4)–1
mM EDTA–0.33 mg of ethidium bromide per ml. Results were documented by
Polaroid photography by using a Land camera and Polapan 556 high-speed films.
RESULTS
Patients and environmental screening. (i) Outbreak.Within
a period of 45 days during the early summer of 1994, five
patients from the hematology ward at the University Hospital
Dijkzigt were diagnosed with invasive aspergillosis (Fig. 1).
During the preceding 24 months, only two patients in the same
ward had been diagnosed with invasive aspergillosis. This in-
dicated a sudden and significant increase in infection inci-
dence. Aspergillus spp. were cultured from BAL fluid from two
patients, without the simultaneous culturing of other patho-
gens. Both patients had chest X-rays consistent with invasive
aspergillosis. Aspergillus spp. were also cultured from biopsy
material from the eyes, from the mastoid air cells, and from the
sinuses sphenoidales of an additional three patients (Table 2).
No other microorganisms were cultured from these biopsy
materials. Calco Fluor White stainings clearly showed the true
invasiveness of the fungi. After prophylactic regimens were
started, no additional patients were diagnosed with invasive
aspergillosis.
(ii) Air samples. Large numbers of aspergilli were cultured
from air samples taken from the outside air and, albeit at lower
densities, from air samples taken within the hospital (Table 3).
Only on two occasions did the number of aspergilli cultured
from samples taken on the hematology ward exceed the num-
bers cultured from samples taken from other departments. On
both occasions the organism in question was A. flavus. Two
HEPA-filtered rooms also yielded significant growth of A. fla-
vus on these occasions. Air samples taken at a nearby demo-
lition site showed heavy growth of aspergilli (A. fumigatus, A.
flavus, and A. niger). However, the number of conidia sharply
decreased away from this site.
(iii) Air-conditioning and filtration systems. In the first 2
weeks that the old hematology ward was closed, the number of
aspergilli cultured sharply decreased. Air samples taken from
above the ceiling plates after this period showed no growth of
fungi, and neither did swabs taken from surfaces that looked
suspect. All samples taken from within the air-conditioning
and filtration systems failed to grow aspergilli. Swabs taken
from HEPA filters and pieces of these filters placed on Sab-
ouraud plates also revealed no fungal growth. Fungal isolates
(all A. fumigatus) were obtained from the inlet filters of the
HEPA filtration systems.
Fungal strains and DNA typing. (i) Fungal isolates. Two
isolates of A. flavus were collected from patients with invasive
disease, hospitalized in the hematology ward. An additional
strain was obtained from the sputum of a patient on another
ward. Twenty-five isolates were obtained from air samples
taken during the study period. Nineteen additional strains
were obtained from other institutions (Table 4).
TABLE 1. DNA sequences of primers used
Primera Code Sequence (59–39) Source or reference
E1 ERIC-1 CAC TTA GGG GTC CTC GAA TGT A 26
E2 ERIC-2 AAG TAA GTG ACT GGG GTG AGC G 26
3 RAPD-1247 AAG AGC CCG T This study
4 RAPD-1254 CCG CAG CCA A This study
5 RAPD-1281 AAC GCG CAA C This study
6 RAPD-1283 GCG ATC CCC A This study
26 BG-2 TAC ATT CGA GGA CCC CTA AGT G This study
28 REP 2-I ICG ICT TAT CIG GCC TAC 26
sp1 Spacer-1 TTG TAC ACA CCG CCC GTC A 10
sp2 Spacer-2 GGT ACC TTA GAT GTT TCA GTT C 10
a Primers 3 and 4 and primers 5 and 6 were used in combination in one assay.
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Three isolates of A. fumigatus from patients with invasive
infection in the hematology ward and four clinical isolates from
patients on other wards were collected. From the environment,
eight strains isolated during the study period were chosen
randomly (Table 5).
(ii) Fungal DNA isolation. The protocol combining grinding
and immediate lysis in guanidium isothiocyanate-containing
buffers enabled high-efficiency, high-quality DNA isolation.
DNA preparations thus obtained allowed reproducible results
by RAPD analysis. This was tested by using different batches of
DNA isolated on different days from different fungal strains
(data not shown).
(iii) Comparing isolates of A. flavus. Full-scale RAPD anal-
ysis was first performed on a selection of the strains from
Rotterdam (n 5 12) (Table 4; Fig. 1). Several different types
were discovered: of 12 isolates, 6 appeared to be unique,
whereas 1 pattern was found 6 times. Analysis of 16 additional
strains from Rotterdam, with three RAPD primers only, re-
vealed genetic heterogeneity in this group; 7 different strains
could be distinguished (data not shown). The pattern that was
common among the first group was again found to be common,
occurring nine times. The other strains appeared to be unique.
Overall, 15 of the 28 nosocomial isolates were identical or
highly similar; one of these was a strain recovered from one of
the patients with invasive disease (patient 4). The combined
RAPD patterns of each of the two other clinical isolates were
unique.
The A. flavus isolates from within the Academic Hospital
Rotterdam could be distinguished from those obtained from
the other institutions. Moreover, these latter isolates could be
differentiated from each other, although identical RAPD re-
sults were sometimes found within geographically clustered
groups (for instance, H3 [884] and H6 [985] [Fig. 2]). Docu-
mentation of possible epidemiological relationships between
these strains was not available. Among the strains from the
University Hospital Nijmegen, five had been derived from a
single deceased patient. Interestingly, post-mortem strains cul-
tured from different organs of this patient were identical but
they differed from a strain isolated from BAL fluid taken
before death.
FIG. 1. Number of patients diagnosed with invasive aspergillosis between 1992 and 1994. The numbers 1 to 12 on the x axis correspond to the months January to
December.









1 (F, 38) Multiple myeloma 27-05-94 Endophthalmitis; A. fumigatus Alive
2 (M, 37) Acute myeloid leukemia 01-06-94 Invasive external otitis; A. flavus Alive
3 (M, 53) Acute lymphocytic leukemia 30-06-94 Pneumonia; A. fumigatus Alive
4 (M, 65) Aplastic anemia 02-07-94 Sinusitis; A. flavus Died
5 (M, 40) Chronic myeloid leukemia 10-07-94 Pneumonia; A. fumigatus Died
a F, female; M, male.
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PCR ribotyping identified two types among the A. flavus
strains. Most of the isolates generated two amplimers (750 and
650 bp in length), whereas a subset of strains gave rise to the
750-bp fragment only. This limited degree of polymorphism
did not add to that revealed by the RAPD assays. One of the
three American A. flavus strains (U3 [isolate no. 31 (506857)]
was the single exception in the sense that only a 450-bp frag-
ment was synthesized. We assume that this particular strain
does not represent A. flavus.
(iv) Comparing isolates of A. fumigatus. Results of RAPD
analysis for the 15 strains studied are shown in Fig. 1; the
interpretation is summarized in Table 5. Nearly all isolates of
A. fumigatus could be differentiated by RAPD analysis using
different primers. One RAPD type (overall RAPD type II) was
found three times; all other combinations were unique. No
RAPD identity between environmental and clinical isolates
was found. The PCR ribotyping assay resulted in the amplifi-
cation of a 1,200-bp DNA fragment for all the strains, thereby
unambiguously identifying the species as A. fumigatus.
(v) General remarks. Figure 2 highlights that in the RAPD
patterns, species-specific DNA fragments (present in all lanes)
could be observed. In this way, isolates of A. flavus and A.
fumigatus could be discriminated quite easily. This was further
confirmed by additional experiments using various other prim-
ers (data not shown). From the overall number of types de-
tectable per primer species, it can be concluded that for both
A. flavus and A. fumigatus combined application of primers 5
and 6 results in adequate demonstration of genetic polymor-
TABLE 3. Number of CFU of all fungi (pathogenic
and nonpathogenic) in the hospital air and the
surroundings during various study periods
Perioda
Fungus CFUb
Outside Hematology ward HEPA-filtered rooms
I 530 (0.9) 9.1 (0.04) 2.0 (0.02)
II 340 (1.3) 2.4 (0.02) 0.3 (0)
III 200 (1.1) 0.8 (0) 0.5 (0.03)
a Period I is the outbreak period, period II is the 2 weeks in which the ward was
closed, and period III is the period in which the air-conditioning systems were
opened and examined. Numbers shown are the average CFU per cubic meter
deduced from totals of 15 m3 (outside), 20 m3 (HEPA-filtered rooms), or 50 m3
(hematology ward).
b The first number refers to all fungi; the number in parentheses refers to
Aspergillus spp. only.
TABLE 4. PCR typing of nosocomial and environmental A. flavus isolates
Isolate no. Code Sourcea Isolation date(day-mo-yr)
Genotype with PCR primer species: Overall RAPD
typeb26 28 3-4 5-6 E1 E2 sp1-sp2
1c 2-9 Sinusitis 02-07-94 A A A A A A A I
2c 1-76 Invasive external otitis 01-06-94 B B B B B B B II
3 6-3 Sputum (patient outside hematology ward) 22-07-94 C A C C A A A III
4 2-45 HEPA (hematology ward) 07-07-94 A A A A A A A I
5 4-62 Hematology ward 19-07-94 A A A A A A A I
6 2-15 Hematology ward 04-07-94 D C D D C B B IV
7 2-36 Internal ward 06-07-94 A A A A A A A I
8 6-46 Environment 05-08-94 E D E E A A A V
9 4-61 Hematology ward 19-07-94 A A A A A A A I
10 4-70 Hematology ward 19-07-94 A A A A A A A I
11 5-73 Environment 26-07-94 F C F F D C A VI
12 5-33 Environment 18-07-94 G E G G A C B VII
13 143 Superficial isolate, RLH NAd H F NDe H E D A VIII
14 2062 Superficial isolate, RLH NA I C A I F A A IX
15 884 Superficial isolate, RLH NA J G A J A E A X
16 1826 Superficial isolate, RLH NA I H H K F F B XI
17 1220 Superficial isolate, RLH NA K I I L G G B XII
18 985 Superficial isolate, RLH NA J G A J A E A X
19 137 Superficial isolate, AHN NA C J C C A A A XIII
20 284 Bronchial isolate, AHN NA L J K N F I B XIV
21 509 BAL isolate, AHN NA M J K N F I B XV
22 510 Obduction isolate, AHN NA N K L O H J B XVI
23 511 Obduction isolate, AHN NA N K L O H J B XVI
24 512 Obduction isolate, AHN NA N K L O H J B XVI
25 513 Obduction isolate, AHN NA N K L O H J B XVI
26 544 Abdominal isolate, AHN NA O J M P I K A XVII
27 744 Superficial isolate, AHN NA C L C C J L A XVIII
28 1023 Superficial isolate, AHN NA J J N J K M A XIX
29 432619 Clinical isolate, USA NA P M O Q A C A XX
30 433771 Clinical isolate, USA NA Q N P R L N A XXI
31 506857 Clinical isolate, USA NA R O Q S M O C XXII
Total no. of types 18 15 17 19 13 15 3 22
a RLH, Regional Laboratory of Public Health Haarlem; AHN, Academic Hospital Nijmegen; USA, Diagnostic Microbiology Laboratory of the University of
Minnesota (Minneapolis).
b The overall PCR type was based on the number of differing banding patterns when results for all assays were combined.
c Clinical isolate of patient listed in Table 2.
d NA, not available.
e ND, not done.
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phisms, even though the use of additional primers resulted in
further differentiation.
DISCUSSION
Nosocomial aspergillosis still poses a significant clinical
problem (1, 13, 18). Although PCR tests for detection of fungi
have been described recently (16, 20), this does not yet allevi-
ate the clinical burden. At present, PCR techniques appear to
be more useful for the typing of fungal isolates (3, 11). Con-
clusions concerning relatedness of clinical and environmental
isolates have often been based on biochemical and species
similarities only. Using these parameters, one would have con-
cluded that the apparent outbreak of invasive aspergillosis
encountered in the summer of 1994 in the University Hospital
Rotterdam was due to at least two different species and that
clinical and environmental strains of each species might be
identical. More information and stronger evidence for the re-
latedness of clinical and environmental strains can be derived
from analyzing their genomes. For this purpose, specialized
PCR techniques are currently being introduced in clinical my-
cology laboratories (3, 7, 8, 11, 14, 21, 24). In the present study,
RAPD assays were applied for the analysis of an outbreak of
invasive aspergillosis due to both A. flavus and A. fumigatus.
Before using RAPD analysis in epidemiologic surveys, one
has to evaluate the extent of the differences in DNA banding
patterns that can be generated. The present study showed that
RAPD analysis could discriminate between strains of A. flavus
and A. fumigatus. Strains of A. flavus could also be discrimi-
nated in this way, but additional discrimination was needed. In
preliminary assays with 24 primers and various combinations
thereof, five additional primers, which increased the degree of
genetic heterogeneity, were selected. Differences among PCR
fingerprints obtained for different strains of A. flavus appeared
smaller than those obtained for strains of A. fumigatus. This
may indicate more-limited chromosomal variation in the
former species or a different genome composition, requiring
other primers. This phenomenon was previously described for
A. nidulans, for which species the spread of a single clone in
extensive areas was reported in surveillance studies (6).
Combination of different RAPD assays discriminated among
nearly all strains of Aspergillus spp. In contrast, PCR ribotyping
presented A. fumigatus strains as a homogeneous group: only a
single amplimer was generated. With A. flavus, two ribotypes
were detected. It has recently been proposed that PCR ri-
botyping may present a broad-spectrum strategy suited for
typing of all sorts of bacterial species (10). However, the res-
olution of this procedure is unacceptably low for Aspergillus sp.
typing studies.
By RAPD analysis, all patients’ strains of A. flavus appeared
to be genetically different. RAPD analysis of the whole collec-
tion of environmental and nosocomial strains of A. flavus re-
peatedly identified one specific genotype among the nosoco-
mial strains. These identical patterns were not caused by a lack
of discriminative power of the RAPD technique, for several
strains of A. flavus collected in other laboratories could be
discriminated with relative ease.
Thus, among the A. flavus strains encountered in the Uni-
versity Hospital Rotterdam, a single clone appeared to pre-
dominate on the hematology ward involved in the outbreak.
We consider two options as possible epidemiological explana-
tions. First, it is possible that this particular strain was brought
to the hospital by the index patient, from whom it subsequently
spread into the hospital environment: the highest concentra-
tions of spores of the common A. flavus type were found during
the days that the patient was diagnosed with this infection. This
possible kind of spread of conidia from a patient or from
patient materials has not been described previously. Alterna-
tively, it is possible that this patient may have been infected by
conidia deriving from an environmental source within or in the
immediate vicinity of the hospital. However, no such source
could be detected upon detailed screening of the wards in-
volved; no fungi were detected in the air-conditioning systems
or on the HEPA filters. No rotting wood or aspergilli growing
on isolation materials were detected. No fungi were grown
from the samples taken from above the ceiling plates. This
TABLE 5. PCR typing of nosocomial and environmental A. fumigatus isolates
Isolate no. Code Sourcea Isolation date(day-mo-yr)
Genotype with PCR primer species: Overall
RAPD
typeb26 28 3-4 5-6 E1 E2 sp1-sp2
1 2-2 CF patient outside hematology ward 01-06-94 A A A A A A A I
2 3-2 Hematology ward 09-07-94 A A B B B B A II
3 3-3 Hematology ward 09-07-94 A A B B B B A II
4 3-25 Environment 13-07-94 B B C C C C A III
5 4-9 Environment 11-07-94 A C D D D D A IV
6 2-1 BAL sample from patient outside
hematology ward
04-07-94 C C D E E E A V
7 3-58 Hematology ward 12-07-94 C A A F B B A VI
8 2-57 Environment 08-07-94 A C A G F A A VII
9 2-32 Internal ward 06-07-94 A A E H G F A VIII
10 5-1 Environment 12-07-94 D B A E H G A IX
11c 2-4 BAL sample from hematologic patient 30-06-94 C C E E I H A X
12 2-3 Pancreatitis 10-06-94 C B B I J I A XI
13c 5-26 BAL sample from hematologic patient 10-07-94 E D F J K J A XII
14c 6-71 Eye of hematologic patient 27-05-94 A C NDd ND L ND A XIII
15 2-6 Abdominal drain 30-05-94 A A B B B B A II
Total no. of types 5 4 6 10 12 10 1 13
a CF, cystic fibrosis.
b The overall PCR type was based on the number of differing banding patterns when results for all assays were combined.
c Clinical isolate of patient listed in Table 2.
d ND, not done.
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strain may have been present prior to the infection period, but
no strains isolated during this period are available. In addition,
no construction activities took place within the hospital at the
time of this apparent outbreak. The heavy growth of aspergilli
from the air samples taken at a nearby demolition site may
have had marginal influence. However, at a distance of 75 m
from this site no increase in the numbers of Aspergillus sp.
spores in comparison with numbers in control samples was
found (the hospital is situated 150 m from this site).
As we did not find genetic relatedness among the clinical
isolates, it is unlikely that the outbreak was a result of conidia
spreading from one single source within the hospital. This
outbreak may have been the result of generally elevated num-
bers of conidia from several Aspergillus sp. clones present in
the outside air. Seasonal variation in Aspergillus sp. spore den-
sity has been reported (17). Why large numbers of conidia
entered the hospital remains unanswered. With renewed in-
structions for handling the air-conditioning systems of HEPA-
filtered rooms, a policy to keep windows closed at all times,
and continued air sampling, it is hoped that subsequent out-
breaks can be prevented.
If knowledge concerning the genetic relatedness of clinical
and environmental isolates is available early in the course of an
apparent outbreak of invasive aspergillosis, it is possible to
start searching for a specific cause. Nonrelatedness of isolates
should lead to investigations of the functioning of the barrier
systems, while relatedness of isolates should induce a search
for a common source.
Therefore, we recommend genotyping and comparison of
nosocomial and environmental isolates of Aspergillus spp. ob-
tained during outbreaks of invasive aspergillosis as soon as
possible. RAPD analysis is a truly rapid and reliable tool at
such times.
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